William Slattery

Transport Corporation of America, Inc. provides a wide range of truckload carriage and logistics services. It provides satellite-based communications with the fleet. The company was founded in 1984 and is headquartered in Eagan, MS.

Amerindo Investment Advisors Inc. is a San Francisco-based firm that manages institutional portfolios having a focus on Internet and Internet related issuers. The firm's separate account business consists of corporate ERISA plans, public pension plans, endowments, foundations, family trusts and high net worth individuals. Amerindo mutual funds are offered for the investor seeking a concentration in emerging technology with a focus on the Internet, health sciences and biotechnology.

SteadyMed Ltd. was engaged in the research, development, and manufacture of pharmaceutical products through the PatchPump technology. Its portfolio included Trevyent for pulmonary arterial hypertension and At Home Patient Analgesia for post-surgical pains. The company was founded on June 15, 2005 and was headquartered in Rehovot, Israel.

Chondrial Therapeutics, Inc. operates as a biotechnology company which focuses on the treatment of rare mitochondrial diseases. Its compound is CTI-1601, which the company is developing as a potential treatment for Friedreich’s Ataxia. The company was founded by Steven R. Plump and Mark R. Payne and is headquartered in Bala Cynwyd, PA.

Bridge Medicines LLC operates as a drug discovery company. It provides spanning therapeutic areas including infectious disease, oncology, neuropsychiatry, and rare diseases. The company was founded on November 1, 2016 and is headquartered in New York, NY.

Appello Pharmaceuticals, Inc. operates as a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease. The company is headquartered in Nashville, TN.

Vescor LLC, engages in the discovery and development autophagy targeted therapeutics for cancer treatment. The firm develops small molecule inhibitors of a number of protein targets at critical nodes of the autophagy cascade, perform investigational new drug (IND) enabling studies, and move these into clinical development. The company was founded by Eileen White and Alec Kimmelman and is headquartered in New York, NY.

Chondrial Therapeutics Holdings LLC engages in operation of a biotechnology firm. The company was founded in 2016 and is headquartered in Bala Cynwyd, PA.

Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York.